Literature DB >> 30125425

Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior.

Gaurav Ghag1,2, Nemil Bhatt1,2, Daniel V Cantu1,2, Marcos J Guerrero-Munoz1,2, Anna Ellsworth1,2, Urmi Sengupta1,2, Rakez Kayed1,2.   

Abstract

Several studies have proposed that fibrillary aggregates of tau and other amyloidogenic proteins are neurotoxic and result in numerous neurodegenerative diseases. However, these studies usually involve sonication or extrusion through needles before experimentation. As a consequence, these methods may fragment large aggregates producing a mixture of aggregated species rather than intact fibrils. Therefore, the results of these experiments may be reflective of other amyloidogenic species, such as oligomers and/or protofibrils/short fibrils. To investigate the effects of sonication on the aggregation of tau and other amyloidogenic proteins, fibrils were prepared and well characterized, then sonicated and evaluated by various biochemical and biophysical methods to identify the aggregated species present. We found that indeed a mixture of aggregated species was present along with short fibrils indicating that sonication leads to impure fibril samples and should be analyzed with caution. Our results corroborate the previous studies showing that sonication of prion and Aβ fibrils leads to the formation of toxic, soluble aggregates. We also show that the oligomeric forms are the most toxic species although it is unclear how sonication causes oligomer formation. Recent results suggest that these small toxic oligomers produced by sonication, rather than the stable fibrillar structures, are prion-like in nature displaying seeding and cross-seeding behavior.
© 2018 The Protein Society.

Entities:  

Keywords:  amyloid; sonication; tau oligomers; tauopathies

Mesh:

Substances:

Year:  2018        PMID: 30125425      PMCID: PMC6201727          DOI: 10.1002/pro.3499

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  52 in total

1.  Template-assisted filament growth by parallel stacking of tau.

Authors:  Martin Margittai; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

2.  Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties.

Authors:  Matthew S Planchard; Sarah E Exley; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  Protein Sci       Date:  2014-08-01       Impact factor: 6.725

3.  Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds.

Authors:  Diana L Castillo-Carranza; Julia E Gerson; Urmi Sengupta; Marcos J Guerrero-Muñoz; Cristian A Lasagna-Reeves; Rakez Kayed
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

5.  Granular tau oligomers as intermediates of tau filaments.

Authors:  Sumihiro Maeda; Naruhiko Sahara; Yuko Saito; Miyuki Murayama; Yuji Yoshiike; Hyonchol Kim; Tomohiro Miyasaka; Shigeo Murayama; Atsushi Ikai; Akihiko Takashima
Journal:  Biochemistry       Date:  2007-03-06       Impact factor: 3.162

6.  Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.

Authors:  Astrid Sydow; Ann Van der Jeugd; Fang Zheng; Tariq Ahmed; Detlef Balschun; Olga Petrova; Dagmar Drexler; Lepu Zhou; Gabriele Rune; Eckhard Mandelkow; Rudi D'Hooge; Christian Alzheimer; Eva-Maria Mandelkow
Journal:  J Neurosci       Date:  2011-02-16       Impact factor: 6.167

7.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

8.  Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Authors:  Michiyo Iba; Jing L Guo; Jennifer D McBride; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.

Authors:  Jessica W Wu; Mathieu Herman; Li Liu; Sabrina Simoes; Christopher M Acker; Helen Figueroa; Joshua I Steinberg; Martin Margittai; Rakez Kayed; Chiara Zurzolo; Gilbert Di Paolo; Karen E Duff
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

10.  The role of tau in neurodegeneration.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2009-03-11       Impact factor: 14.195

View more
  31 in total

1.  TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Authors:  Mauro Montalbano; Salome McAllen; Filippa Lo Cascio; Urmi Sengupta; Stephanie Garcia; Nemil Bhatt; Anna Ellsworth; Eric A Heidelman; Omar D Johnson; Samantha Doskocil; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2020-10-14       Impact factor: 5.996

2.  All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species.

Authors:  Aitor Franco; Pablo Gracia; Adai Colom; José D Camino; José Ángel Fernández-Higuero; Natalia Orozco; Alexander Dulebo; Leonor Saiz; Nunilo Cremades; Jose M G Vilar; Adelina Prado; Arturo Muga
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 3.  Aberrant Synaptic Pruning in CNS Diseases: A Critical Player in HIV-Associated Neurological Dysfunction?

Authors:  Zachary Watson; Shao-Jun Tang
Journal:  Cells       Date:  2022-06-16       Impact factor: 7.666

4.  Three-repeat and four-repeat tau isoforms form different oligomers.

Authors:  Hedieh Shahpasand-Kroner; Jennifer Portillo; Carter Lantz; Paul M Seidler; Natalie Sarafian; Joseph A Loo; Gal Bitan
Journal:  Protein Sci       Date:  2022-01-07       Impact factor: 6.993

Review 5.  The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.

Authors:  Sanjib Guha; Gail V W Johnson; Keith Nehrke
Journal:  Mol Neurobiol       Date:  2020-08-26       Impact factor: 5.590

6.  Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.

Authors:  Courtney K Walker; Kelsey M Greathouse; Benjamin D Boros; Emily H Poovey; Kelsey R Clearman; Raksha Ramdas; Hamad M Muhammad; Jeremy H Herskowitz
Journal:  Neuroscience       Date:  2020-12-17       Impact factor: 3.590

7.  Passive immunization against phosphorylated tau improves features of Huntington's disease pathology.

Authors:  Melanie Alpaugh; Maria Masnata; Aurelie de Rus Jacquet; Eva Lepinay; Hélèna L Denis; Martine Saint-Pierre; Peter Davies; Emmanuel Planel; Francesca Cicchetti
Journal:  Mol Ther       Date:  2022-01-17       Impact factor: 12.910

Review 8.  Retromer dysfunction at the nexus of tauopathies.

Authors:  Sharad Kumar; Timothy J Sargeant; Julian M Carosi; Donna Denton
Journal:  Cell Death Differ       Date:  2021-01-20       Impact factor: 15.828

9.  CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.

Authors:  Chritica Lodder; Isabelle Scheyltjens; Ilie Cosmin Stancu; Kiavash Movahedi; Ilse Dewachter; Pablo Botella Lucena; Manuel Gutiérrez de Ravé; Sarah Vanherle; Tim Vanmierlo; Niels Cremers; Hannah Vanrusselt; Bert Brône; Bernard Hanseeuw; Jean-Noël Octave; Astrid Bottelbergs
Journal:  Acta Neuropathol Commun       Date:  2021-06-08       Impact factor: 7.801

10.  Small heat shock protein 22 kDa can modulate the aggregation and liquid-liquid phase separation behavior of tau.

Authors:  April L Darling; Jan Dahrendorff; Stefan G Creodore; Chad A Dickey; Laura J Blair; Vladimir N Uversky
Journal:  Protein Sci       Date:  2021-03-15       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.